Over the past century of antibiotic discovery and development, the identification of antibacterial small-molecule products of microbial origin following the so-called Waksman Platform has effectively translated into the development of antibiotics. However, in response to the growing threat of antibiotic resistance in bacterial pathogens, there is a pressing need for new antibiotic scaffolds. Taking into account that most microbial species remain uncultured due to our limitations to mimic environmental conditions in the lab, the Waksman Platform is missing a significant number of microbial genomes with potential antibiotic properties. In this sense, the isolation of teixobactin demonstrated that mining of this bacterial dark matter with spec...